Abstract
The occurrence of anti-inflammatory and analgesic pharmaceuticals (AIAPs) in the effluents of 16 hospitals, influent and effluent of wastewater treatment plant (WWTP), the contribution and mass load of each hospital to WWTP influent, and the removal efficiencies in WWTP were investigated. Environmental risk was also evaluated by toxicity tests using organisms from three different trophic levels. Acetaminophen had the highest concentration in summer and winter samples, followed by ketoprofen, ibuprofen, and naproxen. The total daily load of AIAPs detected in influent of WWTP was 1677 mg/day/1000 inhabitants in summer and 5074 mg/day/1000 inhabitants in winter. The contribution of 16 hospitals to the total AIAP load in influent of WWTP was 11.30% in summer and 7.09% in winter. The highest mass loads were calculated as 203 mg/bed.day in general hospital in summer and 300 mg/bed.day in pediatric hospital in winter. The removal efficiencies of AIAPs in WWTP ranged between 13% and 100% in summer and 0.88% and 99% in winter. WWTP is not sufficient to remove all the AIAPs. Diclofenac (in summer), mefenamic acid, indomethacin, and phenylbutazone exhibited poor removal below 50%. The effluents of the WWTP exhibited a low risk for fish and Daphnia magna and an insignificant risk for algae.
Similar content being viewed by others
References
Al Aukidy M, Verlicchi P, Jelic A, Petrovic M, Barcelò D (2012) Monitoring release of pharmaceutical compounds: occurrence and environmental risk assessment of two WWTP effluents and their receiving bodies in the Po Valley, Italy. Sci Total Environ 438:15–25. https://doi.org/10.1016/j.scitotenv.2012.08.061
Aydin S, Aydin ME, Bedük F, Tekinay A, Kilic H (2018) Analysis of diclofenac in water samples using in situ derivatization-vortex-assisted liquid-liquid microextraction with gas chromatography-mass spectrometry. Acta Pharma 68:313–324. https://doi.org/10.2478/acph-2018-0024
Aydin S, Aydin ME, Ulvi A, Kiliç H (2019) Antibiotics in hospital effluents: occurrence, contribution to urban wastewater, removal in a wastewater treatment plant, and environmental risk assessment. Environ Sci Pollut Res 26:544–558. https://doi.org/10.1007/s11356-018-3563-0
Azuma T, Otomo K, Kunitou M, Shimizu M, Hosomaru K, Mikata S, Ishida M, Hisamatsu K, Yunoki A, Mino Y, Hayashi T (2019) Environmental fate of pharmaceutical compounds and antimicrobial resistant bacteria in hospital effluents, and contributions to pollutant loads in the surface waters in Japan. Sci Total Environ 657:476–484. https://doi.org/10.1016/j.scitotenv.2018.11.433
Bedner M, MacCrehan WA (2005) Transformation of acetaminophen by chlorination produces the toxicants 1,4-benzoquinone and N-acetyl-pbenzoquinoneimine. Environ Sci Technol 40:516–522. https://doi.org/10.1021/es0509073
Besse JP, Latour JF, Garric J (2012) Anticancer drugs in surface waters What can say about the occurrence and environmental significance of cytotoxic, cytostatic and endocrine therapy drugs? Environ Int 39:73–86. https://doi.org/10.1016/j.envint.2011.10.002
Biel-Maeso M, Corada-Fernandez C, Lara-Martín PA (2018) Monitoring the occurrence of pharmaceuticals in soils irrigated with reclaimed wastewater. Environ Pollut 235:312–321. https://doi.org/10.1016/j.envpol.2017.12.085
Boyd GR, Reemtsma H, Grimm DA, Mitra S (2003) Pharmaceuticals and personal care products (PPCPs) in surface and treated waters of Louisiana, USA and Ontario, Canada. Sci Total Environ 311:135–149. https://doi.org/10.1016/S0048-9697(03)00138-4
Brodin T, Fick J, Jonsson M, Klaminder J (2013) Dilute concentrations of a psychiatric drug alter behavior of fish from natural populations. Science 339:814–815. https://doi.org/10.1126/science.1226850
Carballa M, Omil M, Lema JM, Llompart M, Garcia-Jares C, Rodriguez I, Gomez M, Ternes T (2004) Behavior of pharmaceuticals, cosmetics and hormones in a sewage treatment plant. Water Res 38:2918–2926. https://doi.org/10.1016/j.watres.2004.03.029
Carmona E, Vicente A, Picó Y (2014) Occurrence of acidic pharmaceuticals and personal care products in Turia River Basin: from waste to drinking water. Sci Total Environ 484:53–63. https://doi.org/10.1016/j.scitotenv.2014.02.085
Cleuvers M (2004) Mixture toxicity of the anti-inflammatory drugs diclofenac, ibuprofen, naproxen, and acetylsalicylic acid. Ecotoxicol Environ Saf 59:309–315. https://doi.org/10.1016/S0147-6513(03)00141-6
Coutu S, Rossi L, Barry DA, Rudaz S, Vemaz N (2013) Temporal variability of antibiotics fluxes in wastewater and contribution from hospitals. PLoS One 8:e53592. https://doi.org/10.1371/journal.pone.0053592
Dai G, Huang J, Chen W, Wang B, Yu G, Deng S (2014) Major pharmaceuticals and personal care products (PPCPs) in wastewater treatment plant and receiving water in Beijing, China, and associated ecological risks. Bull Environ Contam Toxicol 92:655–661. https://doi.org/10.1007/s00128-014-1247-0
Dai G, Wang B, Huang J, Dong R, Deng S, Yu G (2015) Occurrence and source apportionment of pharmaceuticals and personal care products in the Beiyun River of Beijing, China. Chemosphere 119:1033–1039. https://doi.org/10.1016/j.chemosphere.2014.08.056
Daouk S, Chèvre N, Vernaz N, Widmer C, Daali Y, Fleury-Souverain S (2016) Dynamics of active pharmaceutical ingredients loads in a Swiss university hospital wastewaters and prediction of the related environmental risk for the aquatic ecosystems. Sci Total Environ 547:244–253. https://doi.org/10.1016/j.scitotenv.2015.12.117
Daughton CG, Ternes TA (1999) Pharmaceuticals and personal care products in the environment: Agents of subtle change? Environ Health Perspect 107:907–938. https://doi.org/10.1289/ehp.99107s6907
Deblonde T, Hartemann P (2013) Environmental impact of medical prescriptions: assessing the risks and hazards of persistence, bioaccumulation and toxicity of pharmaceuticals. Public Health 127:312–317. https://doi.org/10.1016/j.puhe.2013.01.026
Ekpeghere KI, Lee JW, Kim HY, Shin SK, Oh JE (2017) Determination and characterization of pharmaceuticals in sludge from municipal and livestock wastewater treatment plants. Chemosphere 168:1211–1221. https://doi.org/10.1016/j.chemosphere.2016.10.077
Escher BI, Baumgartner R, Koller M, Treyer K, Lienert J, McArdell CS (2011) Environmental toxicology and risk assessment of pharmaceuticals from hospital wastewater. Water Res 45:75–92. https://doi.org/10.1016/j.watres.2010.08.019
European Commission (2003) Technical Guidance Document on Risk Assessment - Part II - Environmental Risk Assessment. Eur Union 337
European Commission (2018) Commission Implementing Decision (EU) 2018/840 of 5 June 2018 Establishing a Watch List of Substances for Union-wide Monitoring in the Field of Water Policy Pursuant to Directive 2008/105/EC of the European Parliament and of the Council and repealing Commission Implementing Decision (EU) 2015/495
Fatta-Kassinos D, Meric S, Nikolaou A (2011) Pharmaceutical residues in environmental waters and wastewater: current state of knowledge and future research. Anal Bioanal Chem 399:251–275. https://doi.org/10.1007/s00216-010-4300-9
Ferrari B, Paxeus N, Lo Guidice R, Pollio A, Garric J (2003) Ecotoxicological impact of pharmaceuticals found in treated wastewaters: Study of carbamazepine, clofibric acid and diclofenac. Ecotoxicol Environ Saf 55:359–370. https://doi.org/10.1016/S0147-6513(02)00082-9
Ferrari B, Mons R, Vollat BE, Fraysse B, Paxéus N, Lo Giudice R, Pollio A, Garric J (2004) Environmental risk assessment of six human pharmaceuticals: Are the current environmental risk assessment procedures sufficient for the protectıon of the aquatic environment? Environ Toxicol Chem 23:1344–1354. https://doi.org/10.1897/03-246
Focazio MJ, Kolpin DW, Barnes KK, Furlong ET, Meyer MT, Zaugg SD, Barbere LB, Thurman ME (2008) A national reconnaissance for pharmaceuticals and other organic wastewater contaminants in the United States-II, Untreated drinking water sources. Sci Total Environ 402:192–200. https://doi.org/10.1016/j.scitotenv.2008.02.021
Fram MS, Belitz K (2011) Occurrence and concentrations of pharmaceutical compounds in groundwater used for public drinking-water supply in California. Sci Total Environ 409:3409–3417. https://doi.org/10.1016/j.scitotenv.2011.05.053
Gallardo-Altamirano MJ, Maza-Márquez P, Peña-Herrera JM, Rodelas B, Osorio F, Pozo C (2018) Removal of anti-inflammatory/analgesic pharmaceuticals from urban wastewater in a pilot-scale A2O system: Linking performance and microbial population dynamics to operating variables. Sci Total Environ 643:1481–1492. https://doi.org/10.1016/j.scitotenv.2018.06.284
Gomez MJ, Petrovic M, Fernandez-Alba AR, Barcelo D (2006) Determination of pharmaceuticals of various therapeutic classes by solid-phase extraction and liquid chromatography–tandem mass spectrometry analysis in hospital effluent wastewaters. J Chromatogr A 1114:224–233. https://doi.org/10.1016/j.chroma.2006.02.038
Gros M, Petrovic M, Barceló D (2007) Wastewater treatment plants as a pathway for aquatic contamination by pharmaceuticals in the Ebro river basin (northeast Spain). Environ Toxicol Chem 26:1553–1562. https://doi.org/10.1897/06-495R.1
Gros M, Petrovic M, Ginebreda A, Barceló D (2010) Removal of pharmaceuticals during wastewater treatment and environmental risk assessment using hazard indexes. Environ Int 36:15–26. https://doi.org/10.1016/j.envint.2009.09.002
Grung M, Kallqvist T, Sakshaug S, Skurtveit S, Thomas KV (2008) Environmental assessment of Norwegian priority pharmaceuticals based on the EMEA guideline. Ecotoxicol Environ Saf 71:328–340. https://doi.org/10.1016/j.ecoenv.2007.10.015
Guerra P, Kim M, Shah A, Alaee M, Smyth SA (2014) Occurrence and fate of antibiotic, analgesic/anti-inflammatory, and antifungal compounds in five wastewater treatment processes. Sci Total Environ 473-474:235–243. https://doi.org/10.1016/j.scitotenv.2013.12.008
Hoeger B, Köllner B, Dietrich DR, Hitzfeld B (2005) Water-borne diclofenac affects kidney and gill integrity and selected immune parameters in brown trout (Salmo trutta f. fario). Aquat Toxicol 75:53–64. https://doi.org/10.1016/j.aquatox.2005.07.006
Isidori M, Lavorgna M, Nardelli A, Parrella A, Previtera L, Rubino M (2005) Ecotoxicity of naproxen and its phototransformation products. Sci Total Environ 348:93–101. https://doi.org/10.1016/j.scitotenv.2004.12.068
Ivanová L, Mackuľak T, Grabic R, Golovko O, Koba O, Staňová AV, Szabová P, Grenčíková A, Bodík I (2018) Pharmaceuticals and illicit drugs - A new threat to the application of sewage sludge in agriculture. Sci Total Environ 634:606–615. https://doi.org/10.1016/j.scitotenv.2018.04.001
Jelic A, Gros M, Ginebreda A, Cespedes-Sanchez R, Ventura F, Petrovic M, Barcelo D (2011) Occurrence, partition and removal of pharmaceuticals in sewage water and sludge during wastewater treatment. Water Res 45:1165–1176. https://doi.org/10.1016/j.watres.2010.11.010
Jones OAH, Voulvoulis N, Lester JN (2007) The occurrence and removal of selected pharmaceutical compounds in a sewage treatment works utilising activated sludge treatment. Environ Pollut 145:738–744. https://doi.org/10.1016/j.envpol.2005.08.077
Joss A, Keller E, Alder AC, Göbel A, McArdell CS, Ternes T, Siegrist H (2005) Removal of pharmaceuticals and fragrances in biological wastewater treatment. Water Res 39:3139–3152. https://doi.org/10.1016/j.watres.2005.05.031
Kasprzyk-Hordern B, Dinsdal RM, Guwy AJ (2008) The occurrence of pharmaceuticals, personal care products, endocrine disruptors and illicit drugs in surface water in South Wales, UK. Water Res 42:3498–3518. https://doi.org/10.1016/j.watres.2008.04.026
Kasprzyk-Horderna B, Dinsdale RM, Guwy AJ (2009) The removal of pharmaceuticals, personal care products, endocrine disruptors and illicit drugs during wastewater treatment and its impact on the quality of receiving waters. Water Res 43:363–380. https://doi.org/10.1016/j.watres.2008.10.047
Kołecka K, Gajewska M, Stepnowski P, Caban M (2019) Spatial distribution of pharmaceuticals in conventional wastewater treatment plant with Sludge Treatment Reed Beds technology. Sci Total Environ 647:149–157. https://doi.org/10.1016/j.scitotenv.2018.07.439
Kosma CI, Lambropoulou DA, Albanis TA (2010) Occurrence and removal of PPCPs in municipal and hospital wastewaters in Greece. J Hazard Mater 179:804–817. https://doi.org/10.1016/j.jhazmat.2010.03.075
Kosma CI, Lambropoulou DA, Albanisa TA (2014) Investigation of PPCPs in wastewater treatment plants in Greece: Occurrence, removal and environmental risk assessment. Sci Total Environ 466:421–438. https://doi.org/10.1016/j.scitotenv.2013.07.044
Kovalova L, Siegrist H, Singer H, Wittmer A, McArdell CS (2012) Hospital wastewater treatment by membrane bioreactor: Performance and efficiency for organic micropollutant elimination. Environ Sci Technol 46:1536–1545. https://doi.org/10.1021/es203495d
Langford KH, Thomas KV (2009) Determination of pharmaceutical compounds in hospital effluents and their contribution to wastewater treatment works. Environ Int 35:766–770. https://doi.org/10.1016/j.envint.2009.02.007
Lin AYC, Yu TH, Lin CF (2008) Pharmaceutical contamination in residential, industrial, and agricultural waste streams: risk to aqueous environments in Taiwan. Chemosphere 74:131–141. https://doi.org/10.1016/j.chemosphere.2008.08.027
Lindqvist N, Tuhkanen T, Kronberg L (2005) Occurrence of acidic pharmaceuticals in raw and treated sewage and in receiving waters. Water Res 39:2219–2228. https://doi.org/10.1016/j.watres.2005.04.003
Liu J, Lu G, Xie Z, Zhang Z, Li S, Yan Z (2015) Occurrence, bioaccumulation and risk assessment of lipophilic pharmaceutically active compounds in the downstream rivers of sewage treatment plants. Sci Total Environ 511:54–62. https://doi.org/10.1016/j.scitotenv.2014.12.033
Loraine GA, Pettigrove ME (2006) Seasonal variations in concentrations of pharmaceuticals and personal care products in drinking water and reclaimed wastewater in southern California. Environ Sci Technol 40:687–695. https://doi.org/10.1021/es051380x
Lyons G (2014) Pharmaceuticals in the environment: A growing threat to our tap water and wildlife. A CHEM Trust report. http://www.chemtrust.org/wp-content/uploads/CHEM-Trust-Pharma-Dec14.pdf. Accessed 4 Jul 2019
Matamoros V, Arias CA, Nguyen LX, Salvadó V, Brix H (2012) Occurrence and behavior of emerging contaminants in surface water and a restored wetland. Chemosphere 88:1083–1089. https://doi.org/10.1016/j.chemosphere.2012.04.048
Mendoza A, Aceña J, Pérez S, López de Alda M, Barceló D, Gil A, Valcárce Y (2015) Pharmaceuticals and iodinated contrast media in a hospital wastewater: A case study to analyse their presence and characterise their environmental risk and hazard. Environ Res 140:225–241. https://doi.org/10.1016/j.envres.2015.04.003
Metcalf & Eddy (2003) Wastewater Engineering: Treatment and Reuse, 4th edn. McGraw-Hill, New York
Naidoo V, Wolter K, Cromarty D, Diekmann M, Duncan N, Meharg AA, Taggart MA, Venter L, Cuthbert R (2010) Toxicity of non-steroidal anti-inflammatory drugs to Gyps vultures: A new threat from ketoprofen. Biol Lett 6:339–341. https://doi.org/10.1098/rsbl.2009.0818
Nguyen HT, Thai PK, Kaserzon SL, O'Brien JW, Eaglesham G, Mueller JF (2018) Assessment of drugs and personal care products biomarkers in the influent and effluent of two wastewater treatment plants in Ho Chi Minh City, Vietnam. Sci Total Environ 631-632:469–475. https://doi.org/10.1016/j.scitotenv.2018.02.309
Nielsen U, Hastrup C, Klausen MM, Pedersen BM, Kristensen GH, Jansen JLC, Bak SN, Tuerk J (2013) Removal of APIs and bacteria from hospital wastewater by MBR plus O3, O3 + H2O2, PAC or ClO2. Water Sci Technol 67:854–862. https://doi.org/10.2166/wst.2012.645
Nikolaou A, Meric S, Fatta D (2007) Occurrence patterns of pharmaceuticals in water and wastewater environments. Anal Bioanal Chem 387:1225–1234. https://doi.org/10.1007/s00216-006-1035-8
Oaks JL, Gilbert M, Virani MZ, Watson RT, Meteyer CU, Rideout BA, Shivaprasad HL, Ahmed S, Chaudhry MJ, Arshad M, Mahmood S, Ali A, Khan AA (2004) Diclofenac residues as the cause of vulture population decline in Pakistan. Nature 427:630–633. https://doi.org/10.1038/nature02317
Oliveira TS, Murphy M, Mendola N, Wong V, Carlson D, Waring L (2015) Characterization of pharmaceuticals and personal care products in hospital effluent and waste water influent/effluent by direct-injection LC-MS-MS. Sci Total Environ 518-519:459–478. https://doi.org/10.1016/j.scitotenv.2015.02.104
Ort C, Lawrence MG, Reungoat J, Eaglesham G, Carter S, Keller J (2010) Determining the fraction of pharmaceutical residues in wastewater originating from a hospital. Water Res 44:605–615. https://doi.org/10.1016/j.watres.2009.08.002
Paíga P, Correia M, Fernandes MJ, Silva A, Carvalho M, Vieira J, Jorge S, Silva JG, Freire C, Delerue-Matos C (2019) Assessment of 83 pharmaceuticals in WWTP influent and effluent samples by UHPLC-MS/MS: Hourly variation. Sci Total Environ 648:582–600. https://doi.org/10.1016/j.scitotenv.2018.08.129
Papageorgiou M, Kosma C, Lambropoulou D (2016) Seasonal occurrence, removal, mass loading and environmental risk assessment of 55 pharmaceuticals and personal care Escher products in a municipal wastewater treatment plant in Central Greece. Sci Total Environ 543:547–569. https://doi.org/10.1016/j.scitotenv.2015.11.047
Pedrouzo M, Borrull F, Pocurull E, Maria Marcé R (2011) Presence of pharmaceuticals and hormones in waters from sewage treatment plants. Water Air Soil Pollut 217:267–281. https://doi.org/10.1007/s11270-010-0585-8
Perrodin Y, Christine B, Sylvie B, Alain D, Jean-Luc BK, Cécile CO, Audrey R, Elodie B (2013) A priori assessment of ecotoxicological risks linked to building a hospital. Chemosphere 90:1037–1046. https://doi.org/10.1016/j.chemosphere.2012.08.049
Radjenovic J, Petrovic M, Barceló D (2007) Analysis of pharmaceuticals in wastewater and removal using a membrane bioreactor. Anal Bioanal Chem 387:1365–1377. https://doi.org/10.1007/s00216-006-0883-6
Richardson SD, Ternes TA (2011) Water analysis: emerging contaminants and current issues. Anal Chem 83:4614–4648. https://doi.org/10.1021/ac200915r
Rosal R, Rodríguez A, Perdigón-Melón JA, Petre A, García-Calvo E, José Gómez M, Agüera A, Fernández-Alba AR (2010) Occurrence of emerging pollutants in urban wastewater and their removal through biological treatment followed by ozonation. Water Res 44:578–588. https://doi.org/10.1016/j.watres.2009.07.004
Sanderson H, Thomsen M (2009) Comparative analysis of pharmaceuticals versus industrial chemicals acute aquatic toxicity classification according to the United Nations classification system for chemicals. Assessment of the (Q)SAR predictability of pharmaceuticals acute aquatic toxicity and their predominant acute toxic mode-of-action. Toxicol Lett 187:84–93. https://doi.org/10.1016/j.toxlet.2009.02.003
Sanderson H, Johnson DJ, Wilson CJ, Brain RA, Solomon KR (2003) Probabilistic hazard assessment of environmentally occurring pharmaceuticals toxicity to fish, daphnids and algae by ECOSAR screening. Toxicol Lett 144:383–395. https://doi.org/10.1016/S0378-4274(03)00257-1
Santos LH, Gros M, Rodriguez-Mozaz S, Delerue-Matos C, Pena A, Barceló D, Montenegro MC (2013) Contribution of hospital effluents to the load of pharmaceuticals in urban wastewaters: Identification of ecologically relevant pharmaceuticals. Sci Total Environ 461-462:302–316. https://doi.org/10.1016/j.scitotenv.2013.04.077
Sim WJ, Lee JW, Lee ES, Shin SK, Hwang SR, Oh JE (2011) Occurrence and distribution of pharmaceuticals in wastewater from households, livestock farms, hospitals and pharmaceutical manufactures. Chemosphere 82:179–186. https://doi.org/10.1016/j.chemosphere.2010.10.026
Sim WJ, Kim HY, Choi SD, Kwon JH, Oh JE (2013) Evaluation of pharmaceuticals and personal care products with emphasis on anthelmintics in human sanitary waste, sewage, hospital wastewater, livestock wastewater and receiving water. J Hazard Mater 248-249: 219– 227. https://doi.org/10.1016/j.jhazmat.2013.01.007
Stuer-Lauridsen F, Birkved M, Hansen LP, Holten Lützhoft HC, Halling-Sorensen B (2000) Environmental risk assessment of human pharmaceuticals in Denmark after normal therapeutic use. Chemosphere 40:783–793. https://doi.org/10.1016/S0045-6535(99)00453-1
Stumpf M, Ternes TA, Wilken RD, Rodrigues SV, Baumann W (1999) Polar drug residues in sewage and natural waters in the state of Rio de Janeiro, Brazil. Sci Total Environ 225:135–141. https://doi.org/10.1016/S0048-9697(98)00339-8
Suarez S, Lema J, Omil F (2009) Pre-treatment of hospital wastewater by coagulation–flocculation and flotation. Bioresour Technol 100:2138–2146. https://doi.org/10.1016/j.biortech.2008.11.015
Taggart MA, Senacha KR, Green RE, Jhala YV, Raghavan B, Rahmani AR, Cuthbert R, Pain DJ, Meharg AA (2007) Diclofenac residues in carcasses of demostic ungulates available to vultures in India. Environ Int 33:759–765. https://doi.org/10.1016/j.envint.2007.02.010
Tauxe-Wuersch A, De Alencastro LF, Grandjean D, Tarradellas J (2005) Occurrence of several acidic drugs in sewage treatment plants in Switzerland and risk assessment. Water Res 39:1761–1772. https://doi.org/10.1016/j.watres.2005.03.003
Ternes TA, Herrmann N, Bonerz M, Knacker T, Siegrist H, Joss A (2004) A rapid method to measure the solid-water distribution coefficient (Kd) for pharmaceuticals and musk fragrances in sewage sludge. Water Res 38:4075–4084. https://doi.org/10.1016/j.watres.2004.07.015
Thomas KV, Dye C, Schlabach M, Langford KH (2007) Source to sink tracking of selected human pharmaceuticals from two Oslo city hospitals and a wastewater treatment works. J Environ Monit 9:1410–1418. https://doi.org/10.1039/b709745j
Tran NH, Li J, Hu J, Ong SL (2014a) Occurrence and suitability of pharmaceuticals and personal care products as molecular markers for raw wastewater contamination in surface water and groundwater. Environ Sci Pollut Res 21:4727–4740. https://doi.org/10.1007/s11356-013-2428-9
Tran NH, Urase T, Ta TT (2014b) A Preliminary Study on the occurrence of pharmaceutically active compounds in hospital wastewater and surface water in Hanoi, Vietnam. Clean Soil Air Water 42:267–275. https://doi.org/10.1002/clen.201300021
Tran NH, Reinhard M, Yew-Hoong Gin K (2018) Occurrence and fate of emerging contaminants in municipal wastewater treatment plants from different geographical regions. Water Res 133:182–207. https://doi.org/10.1016/j.watres.2017.12.029
Verlicchi P, Galletti A, Petrovic M, Barceló D (2010) Hospital effluents as a source of emerging pollutants: An overview of micropollutants and sustainable treatment options. J Hydrol 389:416–428. https://doi.org/10.1016/j.jhydrol.2010.06.005
Verlicchi P, Al Aukidy M, Galletti A, Petrovic M, Barceló D (2012) Hospital effluent: Investigation of the concentrations and distribution of pharmaceuticals and environmental risk assessment. Sci Total Environ 430:109–118. https://doi.org/10.1016/j.scitotenv.2012.04.055
Verlicchi P, Galletti A, Petrovic M, Barceló D, Al Aukidy M, Zambello E (2013) Removal of selected pharmaceuticals from domestic wastewater in an activated sludge system followed by a horizontal subsurface flow bed-Analysis of their respective contributions. Sci Total Environ 454-455:411–425. https://doi.org/10.1016/j.scitotenv.2013.03.044
Vieno N, Sillanpää M (2014) Fate of diclofenac in municipal wastewater treatment plant-A review. Environ Int 69:28–39. https://doi.org/10.1016/j.envint.2014.03.021
Vieno NM, Härkki H, Tuhkanen T, Kronberg L (2007) Occurrence of pharmaceuticals in river water and theirelimination a pilot-scale drinking water treatment plant. Environ Sci Technol 41:5077–5084. https://doi.org/10.1021/es062720x
Villar-Navarro E, Baena-Nogueras RM, Paniw M, Perales JA, Lara-Martín PA (2018) Removal of pharmaceuticals in urban wastewater: High rate algae pond (HRAP) based technologies as an alternative to activated sludge based processes. Water Res 139:19–29. https://doi.org/10.1016/j.watres.2018.03.072
Vulliet E, Cren-Olivé C, Grenier-Loustalot MF (2011) Occurrence of pharmaceuticals and hormones in drinking water treated from surface waters. Environ Chem Lett 9:103–114. https://doi.org/10.1007/s10311-009-0253-7
Vystavna Y, Huneau F, Grynenko V, Vergeles Y, Celle-Jeanton H, Tapie N (2012) Pharmaceuticals in rivers of two regions with contrasted socio-economic conditions: occurrence, accumulation, and comparison for Ukraine and France. Water Air Soil Pollut 223:2111–2124. https://doi.org/10.1007/s11270-011-1008-1
Wiest L, Chonova T, Bergé A, Baudot R, Bessueille-Barbier F, Ayouni-Derouiche L, Vulliet E (2018) Two-year survey of specific hospital wastewater treatment and its impact on pharmaceutical discharges. Environ Sci Pollut Res 25:9207–9218. https://doi.org/10.1007/s11356-017-9662-5
Xu W, Zhang G, Li X, Zou S, Li P, Hu Z, Li J (2007) Occurrence and elimination of antibiotics at four sewage treatment plants in the Pearl River Delta (PRD), South China. Water Res 41:4526–4534. https://doi.org/10.1016/j.watres.2007.06.023
Yamamoto H, Nakamura Y, Nakamura Y, Kitani C, Imari T, Sekizawa J, Takao Y, Yamashita N, Hirai N, Oda S, Tatarazako N (2007) Initial ecological risk assessment of eight selected human pharmaceuticals in Japan. Environ Sci 14:177–193
Yang G, Fan M, Zhang G (2014) Emerging contaminants in surface waters in China-A short review. Environ Res Lett 9:1–14. https://doi.org/10.1088/1748-9326/9/7/074018
Zorita S, Mårtensson L, Mathiasson L (2009) Occurrence and removal of pharmaceuticals in a municipal sewage treatment system in the south of Sweden. Sci Total Environ 407:2760–2770. https://doi.org/10.1016/j.scitotenv.2008.12.030
Acknowledgments
This work was supported by Turkish Academia of Sciences Awards for Outstanding Young Scientists (TÜBA-GEBIP).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflicts of interest.
Additional information
Responsible Editor: Ester Heath
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Aydin, S., Aydin, M.E. & Ulvi, A. Monitoring the release of anti-inflammatory and analgesic pharmaceuticals in the receiving environment. Environ Sci Pollut Res 26, 36887–36902 (2019). https://doi.org/10.1007/s11356-019-06821-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11356-019-06821-4